Skip to content
healthcare.dev

Regadenoson

NDC 10135-803, Regadenoson, injection, solution, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-803
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218054
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-803 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
10135-803-51101350803511 SYRINGE in 1 CARTON (10135-803-51) / 5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/843bfba9-47de-4d76-843a-997bb4564f6e

Use it

Look up 10135-803 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-803 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-803. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.